Works matching AU Ciuleanu, Tudor
Results: 36
MicroRNAs expression profile in chemotherapy-induced cardiotoxicity in non-small cell lung cancer using a co-culture model.
- Published in:
- Biomolecules & Biomedicine, 2024, v. 24, n. 1, p. 125, doi. 10.17305/bb.2023.9272
- By:
- Publication type:
- Article
How to Diagnose and Treat a Cancer of Unknown Primary Site.
- Published in:
- Journal of Gastrointestinal & Liver Diseases, 2017, v. 26, n. 1, p. 69, doi. 10.15403/jgld.2014.1121.261.haz
- By:
- Publication type:
- Article
5-Fluorouracil Potentiates the Anti-Cancer Effect of Oxaliplatin on Colo320 Colorectal Adenocarcinoma Cells.
- Published in:
- Journal of Gastrointestinal & Liver Diseases, 2013, v. 22, n. 1, p. 37
- By:
- Publication type:
- Article
Novel Cellular and molecular Approaches to stratification and treatment of Colorectal Cancer.
- Published in:
- Journal of Gastrointestinal & Liver Diseases, 2012, v. 21, n. 4, p. 413
- By:
- Publication type:
- Article
Cardiomyopathies and Arrhythmias Induced by Cancer Therapies.
- Published in:
- Biomedicines, 2020, v. 8, n. 11, p. 496, doi. 10.3390/biomedicines8110496
- By:
- Publication type:
- Article
Pathological complete response following cisplatin or carboplatin-based neoadjuvant chemotherapy for triple-negative breast cancer: A systematic review and meta-analysis.
- Published in:
- Experimental & Therapeutic Medicine, 2022, v. 23, n. 1, p. N.PAG
- By:
- Publication type:
- Article
Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Randomised Phase 2 study of maintenance linsitinib (OSI-906) in combination with erlotinib compared with placebo plus erlotinib after platinum-based chemotherapy in patients with advanced non-small cell lung cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efficacy and Safety of Necitumumab Continuation Therapy in the Phase III SQUIRE Study of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancy.
- Published in:
- Journal of Cellular & Molecular Medicine, 2021, v. 25, n. 13, p. 6094, doi. 10.1111/jcmm.16513
- By:
- Publication type:
- Article
FOLFOX4 Plus Cetuximab for Patients With Previously Untreated Metastatic Colorectal Cancer According to Tumor RAS and BRAF Mutation Status: Updated Analysis of the CECOG/CORE 1.2.002 Study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
FOLFOX4 Plus Cetuximab for Patients With Previously Untreated Metastatic Colorectal Cancer According to Tumor RAS an Status: Updated Analysis of the CECOG/CORE 1.2.002 Study.
- Published in:
- Clinical Colorectal Cancer, 2015, v. 14, n. 2, p. 91, doi. 10.1016/j.clcc.2014.12.003
- By:
- Publication type:
- Article
Spectrum of BRCA1/2 Mutations in Romanian Breast and Ovarian Cancer Patients.
- Published in:
- International Journal of Environmental Research & Public Health, 2022, v. 19, n. 7, p. 4314, doi. 10.3390/ijerph19074314
- By:
- Publication type:
- Article
A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Darbepoetin alfa 300 or 500 μg once every 3 weeks with or without intravenous Iron in patients with chemotherapy-induced anemia.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 9, p. 655, doi. 10.1002/ajh.21779
- By:
- Publication type:
- Article
5-Azacytidine treatment inhibits the development of lung cancer models via epigenetic reprogramming and activation of cellular pathways with anti-tumor activity.
- Published in:
- Medicine & Pharmacy Reports: Clujul Medical, 2024, v. 97, n. 4, p. 488, doi. 10.15386/mpr-2777
- By:
- Publication type:
- Article
Next-generation sequencing as a valuable tool for mutational spectrum in advanced-stage NSCLC patients.
- Published in:
- Medicine & Pharmacy Reports: Clujul Medical, 2024, v. 97, n. 3, p. 298, doi. 10.15386/mpr-2763
- By:
- Publication type:
- Article
Potential Biomarkers for the Efficacy of PD-1-PD-L Blockade in Cancer.
- Published in:
- OncoTargets & Therapy, 2021, v. 14, p. 5275, doi. 10.2147/OTT.S283892
- By:
- Publication type:
- Article
Profiling immunohistochemical expression of NOTCH1-3, JAGGED1, cMET, and phospho-MAPK in 100 carcinomas of unknown primary.
- Published in:
- Clinical & Experimental Metastasis, 2012, v. 29, n. 6, p. 603, doi. 10.1007/s10585-012-9474-4
- By:
- Publication type:
- Article
Central and Eastern European Experience with Sunitinib in Metastatic Renal Cell Carcinoma: A Sub-analysis of the Global Expanded-Access Trial.
- Published in:
- Pathology & Oncology Research, 2015, v. 21, n. 3, p. 775, doi. 10.1007/s12253-014-9889-0
- By:
- Publication type:
- Article
Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe.
- Published in:
- International Journal of Cancer, 2018, v. 142, n. 1, p. 66, doi. 10.1002/ijc.31023
- By:
- Publication type:
- Article
The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial.
- Published in:
- International Journal of Cancer, 2010, v. 127, n. 9, p. 2209, doi. 10.1002/ijc.25423
- By:
- Publication type:
- Article
Treatment patterns, testing practices, and outcomes in the pre-FLAURA era for patients with EGFR mutation-positive advanced NSCLC: a retrospective chart review (REFLECT).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211059874
- By:
- Publication type:
- Article
Treatment patterns, testing practices, and outcomes in the pre-FLAURA era for patients with EGFR mutation-positive advanced NSCLC: a retrospective chart review (REFLECT).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211059874
- By:
- Publication type:
- Article
A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 3, p. 1216, doi. 10.1007/s10637-011-9687-4
- By:
- Publication type:
- Article
Erratum to: A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy.
- Published in:
- 2012
- By:
- Publication type:
- Correction Notice
Exposure-response relationship of ramucirumab in patients with advanced second-line colorectal cancer: exploratory analysis of the RAISE trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pharmacokinetic evaluation of platinum derived from cisplatin administered alone and with pemetrexed in head and neck cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 233, doi. 10.1007/s00280-008-0853-0
- By:
- Publication type:
- Article
Health-Related Quality of Life Outcomes With Two Different Starting Doses of Lenvatinib in Combination With Everolimus for Previously Treated Renal Cell Carcinoma.
- Published in:
- Oncologist, 2023, v. 28, n. 1, p. 59, doi. 10.1093/oncolo/oyac142
- By:
- Publication type:
- Article
Access to Novel Drugs for Non‐Small Cell Lung Cancer in Central and Southeastern Europe: A Central European Cooperative Oncology Group Analysis.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e598, doi. 10.1634/theoncologist.2019-0523
- By:
- Publication type:
- Article
Use of Different Anti-PD-1 Checkpoint Combination Strategies for First-Line Advanced NSCLC Treatment—The Experience of Ion Chiricuță Oncology Institute.
- Published in:
- Cancers, 2024, v. 16, n. 11, p. 2022, doi. 10.3390/cancers16112022
- By:
- Publication type:
- Article
Exploring Therapeutic Avenues in Lung Cancer: The Epigenetic Perspective.
- Published in:
- Cancers, 2023, v. 15, n. 22, p. 5394, doi. 10.3390/cancers15225394
- By:
- Publication type:
- Article
Namodenoson in Advanced Hepatocellular Carcinoma and Child–Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical Trial.
- Published in:
- Cancers, 2021, v. 13, n. 2, p. 187, doi. 10.3390/cancers13020187
- By:
- Publication type:
- Article
Some ethical aspects concerning the chemotherapy treatment of small animals in veterinary medicine.
- Published in:
- Journal Plus Education / Educaţia Plus, 2015, v. 12A, p. 86
- By:
- Publication type:
- Article
Real-World Testing Practices, Treatment Patterns and Clinical Outcomes in Patients from Central Eastern Europe with EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Retrospective Chart Review Study (REFLECT).
- Published in:
- Current Oncology, 2022, v. 29, n. 8, p. 5833, doi. 10.3390/curroncol29080460
- By:
- Publication type:
- Article
Cardiotoxicity Associated with Chemotherapy Used in Gastrointestinal Tumours.
- Published in:
- Medicina (1010660X), 2021, v. 57, n. 8, p. 1, doi. 10.3390/medicina57080806
- By:
- Publication type:
- Article